We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.39B
AUM Growth
+$118M
Cap. Flow
-$190M
Cap. Flow %
-4.31%
Top 10 Hldgs %
15.83%
Holding
1,464
New
104
Increased
519
Reduced
644
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 15.67%
2 Healthcare 11.79%
3 Financials 11.13%
4 Industrials 8.9%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DES icon
751
WisdomTree US SmallCap Dividend Fund
DES
$2.22B
$835K 0.02%
29,369
+4,769
+19% +$137K
ECL icon
752
Ecolab
ECL
$78.8B
$835K 0.02%
5,737
-1,268
-18% -$186K
HPE icon
753
Hewlett Packard
HPE
$75.3B
$829K 0.02%
51,913
+17,238
+50% +$254K
VVV icon
754
Valvoline
VVV
$4.26B
$825K 0.02%
25,274
FVC icon
755
First Trust Dorsey Wright Dynamic Focus 5 ETF
FVC
$110M
$820K 0.02%
23,427
-414
-2% -$14.6K
OTIS icon
756
Otis Worldwide
OTIS
$28B
$817K 0.02%
10,431
+637
+7% +$47K
PH icon
757
Parker-Hannifin
PH
$135B
$816K 0.02%
2,804
-5,170
-65% -$1.48M
SCHP icon
758
Schwab US TIPS ETF
SCHP
$16.2B
$810K 0.02%
31,278
-5,132
-14% -$134K
GDXJ icon
759
VanEck Junior Gold Miners ETF
GDXJ
$8.54B
$810K 0.02%
22,709
+1,019
+5% +$33.5K
FLNG icon
760
FLEX LNG
FLNG
$1.59B
$808K 0.02%
+24,730
New +$827K
MRSH
761
Marsh
MRSH
$90.3B
$801K 0.02%
4,843
+80
+2% +$13.1K
IEF icon
762
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
$800K 0.02%
8,353
-13,650
-62% -$1.31M
CEG icon
763
Constellation Energy
CEG
$98.9B
$799K 0.02%
9,266
-367
-4% -$33K
PLTR icon
764
Palantir
PLTR
$413B
$793K 0.02%
123,503
-33,473
-21% -$254K
SCZ icon
765
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
$782K 0.02%
13,841
+114
+0.8% +$6.12K
ROBO icon
766
ROBO Global Robotics & Automation Index ETF
ROBO
$2.12B
$776K 0.02%
16,756
+3,544
+27% +$162K
PHYS icon
767
Sprott Physical Gold
PHYS
$15.9B
$772K 0.02%
54,776
+14,099
+35% +$188K
AGCO icon
768
AGCO
AGCO
$7.1B
$767K 0.02%
5,528
+2,358
+74% +$291K
CRSP icon
769
CRISPR Therapeutics
CRSP
$5.2B
$762K 0.02%
18,746
-1,031
-5% -$54.7K
BTAL icon
770
AGF US Market Neutral Anti-Beta Fund
BTAL
$299M
$762K 0.02%
+35,919
New +$745K
BEN icon
771
Franklin Resources
BEN
$17B
$759K 0.02%
28,787
-6,250
-18% -$155K
AZN icon
772
AstraZeneca
AZN
$245B
$758K 0.02%
5,593
+83
+2% +$10.4K
REYN icon
773
Reynolds Consumer Products
REYN
$5.54B
$757K 0.02%
25,266
+470
+2% +$14.1K
BJRI icon
774
BJ's Restaurants
BJRI
$1.47B
$754K 0.02%
+28,567
New +$835K
AAL icon
775
American Airlines Group
AAL
$9.96B
$752K 0.02%
59,114
-6,685
-10% -$90.6K

Similar funds

Oppenheimer & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Oppenheimer & Co held 1,464 positions worth $4.39B, up 2.8% from $4.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oppenheimer & Co withdrew a net $190M in Q4 2022, closing 116 positions and reducing 644 holdings. Its most notable exit was State Street SPDR Portfolio Mortgage Backed Bond ETF, an estimated $8.22M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in State Street SPDR Portfolio S&P 500 Value ETF worth $5.18M.

  • Oppenheimer & Co's largest Q4 2022 buy was State Street SPDR Portfolio S&P 500 Value ETF: 133,272 shares worth $5.18M.
  • Oppenheimer & Co added most to iShares Treasury Floating Rate Bond ETF in Q4 2022, an estimated $5.9M increase.
  • Oppenheimer & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $22.8M.
  • Oppenheimer & Co fully exited State Street SPDR Portfolio Mortgage Backed Bond ETF in Q4 2022, selling an estimated $8.22M.
  • Oppenheimer & Co's ten largest holdings make up 16% of its $4.39B portfolio in Q4 2022.
  • Oppenheimer & Co opened 104 new positions and closed 116 in Q4 2022.
  • Oppenheimer & Co's portfolio value rose 2.8% quarter-over-quarter to $4.39B.

Based on Oppenheimer & Co's 13F filing for Q4 2022, filed 8 Feb 2023.